There was no significant association between BRAF-V600E and age, sex, ethnicity, multifocality, lymphocytic thyroiditis, lymph node positivity, ETE, residual tumor, RAI therapy, mortality or M stage (all P≥0.05). This evidence concerns the gene BRAF and neoplasm.